DALBAVANCIN

DALBAVANCIN was reported 1005 times

DALBAVANCIN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 APPLICATION SITE STREAKING 1 0.0769
1 NOCTURNAL HYPERTENSION 1 0.0455
2 PROSTATIC CYST 1 0.0345
3 ADMINISTRATION SITE CELLULITIS 1 0.0286
4 TENDON TRANSFER 1 0.0238
5 AMPUTEE 1 0.0152
6 ADMINISTRATION SITE WARMTH 1 0.0122
7 VASCULAR ACCESS SITE EXTRAVASATION 1 0.0115
8 VANCOMYCIN INFUSION REACTION 4 0.0106
9 INFUSION SITE HYPOAESTHESIA 1 0.0105
10 VASCULAR SKIN DISORDER 1 0.0101
11 COAGULATION TIME ABNORMAL 3 0.0100
12 INFUSION SITE PARAESTHESIA 1 0.0099
13 CYSTIC FIBROSIS LUNG 1 0.0078
14 INFUSION SITE THROMBOSIS 2 0.0075
15 APPLICATION SITE NODULE 1 0.0073
16 THERAPEUTIC PRODUCT CROSS-REACTIVITY 6 0.0067
17 PARASPINAL ABSCESS 1 0.0065
18 CARCINOMA IN SITU 1 0.0060
19 IMMUNE EFFECTOR CELL-ASSOCIATED HAEMATOTOXICITY 1 0.0057
20 JEJUNOSTOMY 1 0.0055
21 BREATH HOLDING 2 0.0052
22 GREATER TROCHANTERIC PAIN SYNDROME 1 0.0049
23 POST PROCEDURAL FEVER 1 0.0041
24 INCISION SITE ABSCESS 1 0.0038
25 EYE HAEMATOMA 1 0.0038
26 PALPABLE PURPURA 1 0.0036
27 RELAPSING FEVER 1 0.0035
28 RED MAN SYNDROME 3 0.0034
29 VULVOVAGINITIS 1 0.0034
30 INFUSION SITE EXTRAVASATION 21 0.0034
31 HYPOPROTHROMBINAEMIA 1 0.0033
32 INFUSION SITE NODULE 3 0.0031
33 ADMINISTRATION SITE SWELLING 1 0.0031
34 VULVITIS 1 0.0030
35 CATHETER SITE IRRITATION 1 0.0030
36 GRANULOMA ANNULARE 2 0.0027
37 HUMAN RHINOVIRUS TEST POSITIVE 1 0.0027
38 SENSATION OF BLOOD FLOW 1 0.0026
39 UREAPLASMA INFECTION 1 0.0025
40 NEUTRALISING ANTIBODIES POSITIVE 1 0.0024
41 GASTROINTESTINAL HYPERMOTILITY 1 0.0023
42 CERVICITIS 1 0.0022
43 PRODUCT RECONSTITUTION QUALITY ISSUE 2 0.0022
44 GASTROINTESTINAL STOMA OUTPUT INCREASED 1 0.0021
45 INFUSION SITE HAEMATOMA 1 0.0021
46 CROSS SENSITIVITY REACTION 2 0.0021
47 ADMINISTRATION SITE EXTRAVASATION 2 0.0020
48 SEPSIS SYNDROME 1 0.0020
49 SUSPECTED PRODUCT CONTAMINATION 2 0.0020
50 MALE ORGASMIC DISORDER 1 0.0019
51 CORYNEBACTERIUM INFECTION 1 0.0019
52 OSTEOMYELITIS ACUTE 1 0.0018
53 TYPE III IMMUNE COMPLEX MEDIATED REACTION 1 0.0018
54 ORTHOSTATIC HYPERTENSION 1 0.0017
55 SERUM SICKNESS-LIKE REACTION 1 0.0016
56 CHONDROCALCINOSIS 1 0.0015
57 INFUSION SITE URTICARIA 1 0.0015
58 INFUSION SITE RASH 2 0.0015
59 BLISTER RUPTURE 1 0.0013
60 EOSINOPHIL COUNT ABNORMAL 1 0.0013
61 AMPHETAMINES POSITIVE 1 0.0013
62 MULTIPLE-DRUG RESISTANCE 4 0.0013
63 BLISTER INFECTED 1 0.0013
64 DEAFNESS NEUROSENSORY 4 0.0012
65 GLOMERULAR FILTRATION RATE INCREASED 1 0.0012
66 INFUSION SITE OEDEMA 1 0.0012
67 SUPERFICIAL VEIN THROMBOSIS 1 0.0012
68 PERIORBITAL PAIN 1 0.0012
69 PRODUCT PREPARATION ERROR 24 0.0012
70 ENTEROCUTANEOUS FISTULA 1 0.0011
71 INCORRECT PRODUCT FORMULATION ADMINISTERED 1 0.0011
72 OTOTOXICITY 2 0.0011
73 TONGUE INJURY 1 0.0011
74 RED BLOOD CELL ABNORMALITY 1 0.0010
75 DISCOLOURED VOMIT 1 0.0010
76 VOMITING PROJECTILE 3 0.0010
77 RED BLOOD CELLS URINE POSITIVE 1 0.0010
78 INFUSION SITE REACTION 3 0.0010
79 FOAMING AT MOUTH 2 0.0010
80 PATHOGEN RESISTANCE 9 0.0010
81 SKIN SENSITISATION 1 0.0010
82 INFUSION SITE DISCOMFORT 1 0.0010
83 INFUSION SITE SWELLING 6 0.0010
84 BONE NEOPLASM 1 0.0009
85 INFECTION REACTIVATION 1 0.0009
86 ADMINISTRATION SITE PAIN 1 0.0009
87 CHRONIC SPONTANEOUS URTICARIA 1 0.0009
88 ARTHRITIS INFECTIVE 4 0.0009
89 EAR PRURITUS 3 0.0009
90 PROSTATIC OPERATION 1 0.0008
91 INTRA-ABDOMINAL HAEMATOMA 1 0.0008
92 ENDOCARDITIS 4 0.0008
93 INFUSION SITE IRRITATION 1 0.0008
94 PRODUCT PREPARATION ISSUE 5 0.0008
95 FLANK PAIN 7 0.0007
96 TYPE IV HYPERSENSITIVITY REACTION 2 0.0007
97 EXTRAVASATION 3 0.0007
98 DIABETIC FOOT INFECTION 1 0.0007
99 VASCULAR INJURY 1 0.0007
100 STAPHYLOCOCCAL BACTERAEMIA 3 0.0007
101 FOOT AMPUTATION 1 0.0007
102 NEPHRECTOMY 1 0.0007
103 MIXED LIVER INJURY 2 0.0007
104 URINE ABNORMALITY 3 0.0007
105 BLOOD PRESSURE IMMEASURABLE 1 0.0007
106 MYELITIS 1 0.0006
107 LIMB DEFORMITY 1 0.0006
108 TINEA PEDIS 1 0.0006
109 INFUSION SITE PAIN 8 0.0006
110 INFUSION SITE HAEMORRHAGE 2 0.0006
111 SYSTEMIC INFECTION 1 0.0006
112 GLOSSITIS 2 0.0006
113 JUGULAR VEIN THROMBOSIS 1 0.0006
114 INDURATION 1 0.0006
115 PNEUMONIA KLEBSIELLA 1 0.0005
116 INJECTION SITE CELLULITIS 1 0.0005
117 MECHANICAL VENTILATION 1 0.0005
118 HYPERVENTILATION 3 0.0005
119 HYPERTRIGLYCERIDAEMIA 3 0.0005
120 RENAL TUBULAR NECROSIS 5 0.0005
121 JOINT NOISE 1 0.0005
122 PNEUMONIA STAPHYLOCOCCAL 1 0.0005
123 EMPYEMA 1 0.0005
124 DEVICE RELATED SEPSIS 1 0.0005
125 PERIPHERAL VENOUS DISEASE 2 0.0005
126 ANAPHYLACTOID REACTION 2 0.0005
127 INSULIN RESISTANCE 1 0.0005
128 WALKING DISABILITY 1 0.0005
129 INFUSION SITE ERYTHEMA 4 0.0005
130 POOR QUALITY PRODUCT ADMINISTERED 5 0.0005
131 EAR SWELLING 1 0.0005
132 PURULENT DISCHARGE 2 0.0005
133 NOSOCOMIAL INFECTION 1 0.0005
134 INFUSION RELATED REACTION 30 0.0005
135 ABDOMINAL ABSCESS 2 0.0005
136 ANAPHYLACTIC REACTION 25 0.0005
137 APPLICATION SITE URTICARIA 1 0.0004
138 HAEMATOTOXICITY 4 0.0004
139 VARICELLA 1 0.0004
140 WEIGHT ABNORMAL 1 0.0004
141 PULSE ABNORMAL 1 0.0004
142 STARING 1 0.0004
143 LIQUID PRODUCT PHYSICAL ISSUE 3 0.0004
144 PHARYNGEAL SWELLING 4 0.0004
145 INJECTION SITE EXTRAVASATION 5 0.0004
146 DEVICE INFUSION ISSUE 1 0.0004
147 GASTROINTESTINAL TUBE INSERTION 1 0.0004
148 VEIN DISORDER 2 0.0004
149 PLATELET DISORDER 1 0.0004
150 PHLEBITIS 2 0.0004
151 HEPATOSPLENOMEGALY 1 0.0004
152 PRODUCT COLOUR ISSUE 2 0.0004
153 MEAN CELL VOLUME INCREASED 1 0.0004
154 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 4 0.0004
155 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 10 0.0004
156 CYANOSIS 6 0.0004
157 BREAST SWELLING 1 0.0004
158 SKIN WRINKLING 1 0.0004
159 RASH MORBILLIFORM 1 0.0004
160 STREPTOCOCCAL INFECTION 2 0.0004
161 HEPATOTOXICITY 8 0.0004
162 SERUM SICKNESS 1 0.0004
163 LUNG CONSOLIDATION 1 0.0004
164 MULTIPLE USE OF SINGLE-USE PRODUCT 2 0.0004
165 NEUTROPHIL COUNT ABNORMAL 1 0.0004
166 FORCED EXPIRATORY VOLUME DECREASED 1 0.0004
167 DRUG RESISTANCE 9 0.0004
168 PHARYNGEAL DISORDER 1 0.0003
169 FIBULA FRACTURE 1 0.0003
170 FINE MOTOR SKILL DYSFUNCTION 1 0.0003
171 ESCHERICHIA SEPSIS 1 0.0003
172 BILIARY COLIC 1 0.0003
173 STRIDOR 1 0.0003
174 BACTERAEMIA 4 0.0003
175 STAPHYLOCOCCAL INFECTION 11 0.0003
176 METABOLIC ENCEPHALOPATHY 1 0.0003
177 GANGRENE 2 0.0003
178 PRURITUS GENERALISED 7 0.0003
179 INFUSION SITE PRURITUS 1 0.0003
180 THROAT IRRITATION 14 0.0003
181 ACUTE RESPIRATORY FAILURE 6 0.0003
182 BACTERIAL SEPSIS 1 0.0003
183 INJECTION SITE INFECTION 1 0.0003
184 TOXIC SKIN ERUPTION 3 0.0003
185 WOUND DEHISCENCE 1 0.0003
186 THROAT TIGHTNESS 8 0.0003
187 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 5 0.0003
188 WOUND COMPLICATION 1 0.0003
189 INTERNATIONAL NORMALISED RATIO ABNORMAL 1 0.0003
190 CERVICAL VERTEBRAL FRACTURE 1 0.0003
191 BLOOD CREATININE ABNORMAL 1 0.0003
192 HYPERTRANSAMINASAEMIA 2 0.0003
193 EOSINOPHILIA 5 0.0003
194 MUSCLE CONTRACTIONS INVOLUNTARY 1 0.0003
195 CLOSTRIDIUM DIFFICILE COLITIS 3 0.0003
196 PRODUCT CONTAMINATION 1 0.0003
197 OSTEOMYELITIS 5 0.0003
198 SKIN LACERATION 3 0.0003
199 SCLERODERMA 1 0.0003
200 PRODUCT STORAGE ERROR 24 0.0003
201 CUTANEOUS VASCULITIS 1 0.0003
202 CHEST DISCOMFORT 28 0.0003
203 LIP SWELLING 9 0.0003
204 CHEMOTHERAPY 1 0.0003
205 RASH MACULAR 9 0.0003
206 PALLOR 7 0.0003
207 WOUND SECRETION 1 0.0003
208 BACK PAIN 59 0.0003
209 RENAL CYST 2 0.0003
210 EXPOSURE VIA BREAST MILK 1 0.0003
211 HYPERPHAGIA 1 0.0003
212 HYPERSENSITIVITY 46 0.0002
213 POST PROCEDURAL INFECTION 2 0.0002
214 TRIGGER FINGER 1 0.0002
215 ARTHRITIS BACTERIAL 1 0.0002
216 PULSELESS ELECTRICAL ACTIVITY 1 0.0002
217 CELLULITIS 12 0.0002
218 HYPERPYREXIA 1 0.0002
219 ESCHERICHIA URINARY TRACT INFECTION 1 0.0002
220 PRODUCT DISPENSING ISSUE 1 0.0002
221 PSEUDOMONAS INFECTION 2 0.0002
222 LIVER FUNCTION TEST INCREASED 5 0.0002
223 URTICARIA 39 0.0002
224 ANAPHYLACTIC SHOCK 6 0.0002
225 DRUG ERUPTION 4 0.0002
226 CATHETERISATION CARDIAC 1 0.0002
227 WHEELCHAIR USER 1 0.0002
228 ANAL INCONTINENCE 2 0.0002
229 CHILLS 26 0.0002
230 OROPHARYNGEAL DISCOMFORT 2 0.0002
231 SUSPECTED OFF LABEL USE 1 0.0002
232 VASCULAR DEVICE INFECTION 1 0.0002
233 RASH 96 0.0002
234 BLOOD PRESSURE DIASTOLIC INCREASED 1 0.0002
235 INTERCEPTED MEDICATION ERROR 1 0.0002
236 FEELING COLD 6 0.0002
237 VAGINAL INFECTION 1 0.0002
238 SINUS TACHYCARDIA 3 0.0002
239 BRONCHOSPASM 3 0.0002
240 NON-SMALL CELL LUNG CANCER 1 0.0002
241 RASH VESICULAR 1 0.0002
242 FLUSHING 21 0.0002
243 ERYTHEMA 42 0.0002
244 HYPERVOLAEMIA 1 0.0002
245 INFLAMMATORY MARKER INCREASED 1 0.0002
246 ABDOMINAL TENDERNESS 1 0.0002
247 PROTEIN URINE PRESENT 1 0.0002
248 DRUG TOLERANCE 1 0.0002
249 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 1 0.0002
250 TOE AMPUTATION 1 0.0002
251 FEELING HOT 12 0.0002
252 PHARYNGEAL OEDEMA 3 0.0002
253 INCREASED UPPER AIRWAY SECRETION 1 0.0002
254 PERIORBITAL OEDEMA 1 0.0002
255 SWOLLEN TONGUE 6 0.0002
256 BLOOD LACTIC ACID INCREASED 1 0.0002
257 POLYARTHRITIS 1 0.0002
258 ANORECTAL DISCOMFORT 1 0.0002
259 ABSCESS 3 0.0002
260 MUSCLE TIGHTNESS 3 0.0002
261 NORMAL NEWBORN 1 0.0002
262 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 1 0.0002
263 WOUND INFECTION 2 0.0002
264 JAW DISORDER 1 0.0002
265 ANGIOEDEMA 8 0.0002
266 RASH MACULO-PAPULAR 4 0.0002
267 HYPERTENSIVE CRISIS 2 0.0002
268 SKIN INFECTION 2 0.0002
269 BLISTER 10 0.0002
270 SKIN TOXICITY 1 0.0002
271 MUSCULOSKELETAL DISCOMFORT 3 0.0002
272 MOUTH SWELLING 1 0.0002
273 METABOLIC DISORDER 1 0.0002
274 VASCULITIS 2 0.0002
275 SPINAL PAIN 2 0.0002
276 COLD SWEAT 3 0.0002
277 OFF LABEL USE 148 0.0002
278 ATAXIA 2 0.0002
279 LEUKOCYTOSIS 3 0.0002
280 TENDON RUPTURE 2 0.0002
281 INJECTION SITE DISCOLOURATION 2 0.0002
282 TUBULOINTERSTITIAL NEPHRITIS 3 0.0002
283 SWELLING OF EYELID 1 0.0002
284 APPLICATION SITE VESICLES 1 0.0002
285 HERPES SIMPLEX 1 0.0002
286 DRUG SPECIFIC ANTIBODY PRESENT 1 0.0002
287 PRURITUS 59 0.0002
288 SKIN DISCOLOURATION 7 0.0002
289 HYPOGAMMAGLOBULINAEMIA 1 0.0002
290 GAIT INABILITY 5 0.0001
291 POSTOPERATIVE WOUND INFECTION 1 0.0001
292 ECCHYMOSIS 1 0.0001
293 FORMICATION 1 0.0001
294 OXYGEN SATURATION DECREASED 8 0.0001
295 SKIN REACTION 2 0.0001
296 PAPULE 1 0.0001
297 PULMONARY TOXICITY 1 0.0001
298 SEASONAL ALLERGY 2 0.0001
299 FAECES SOFT 1 0.0001
300 BLOOD PRESSURE DIASTOLIC DECREASED 1 0.0001
301 STEVENS-JOHNSON SYNDROME 3 0.0001
302 EYE SWELLING 5 0.0001
303 ACUTE KIDNEY INJURY 20 0.0001
304 CHEST PAIN 24 0.0001
305 PRODUCT ADMINISTRATION INTERRUPTED 1 0.0001
306 FURUNCLE 1 0.0001
307 SENSORY LOSS 1 0.0001
308 HYPERHIDROSIS 16 0.0001
309 LOCALISED INFECTION 3 0.0001
310 LACTIC ACIDOSIS 4 0.0001
311 EMBOLISM 1 0.0001
312 MUSCLE SPASMS 22 0.0001
313 SENSATION OF FOREIGN BODY 1 0.0001
314 CARDIOVASCULAR DISORDER 3 0.0001
315 HEPATITIS 3 0.0001
316 PERIPHERAL SWELLING 18 0.0001
317 HYSTERECTOMY 1 0.0001
318 RESPIRATORY SYNCYTIAL VIRUS INFECTION 1 0.0001
319 PURPURA 1 0.0001
320 RESPIRATORY RATE INCREASED 1 0.0001
321 BONE DISORDER 2 0.0001
322 RESPIRATORY ARREST 3 0.0001
323 VOMITING 51 0.0001
324 HEPATIC ENCEPHALOPATHY 1 0.0001
325 SQUAMOUS CELL CARCINOMA 1 0.0001
326 BLOOD SODIUM DECREASED 2 0.0001
327 BLOOD URINE PRESENT 2 0.0001
328 INTERNATIONAL NORMALISED RATIO INCREASED 3 0.0001
329 SUPRAVENTRICULAR TACHYCARDIA 1 0.0001
330 WHITE BLOOD CELL COUNT INCREASED 4 0.0001
331 TACHYCARDIA 9 0.0001
332 PYREXIA 35 0.0001
333 LIGAMENT SPRAIN 1 0.0001
334 SINUS DISORDER 2 0.0001
335 HYPOTONIA 1 0.0001
336 LEUKOPENIA 5 0.0001
337 VAGINAL DISCHARGE 1 0.0001
338 HYPOTHERMIA 1 0.0001
339 NEUTROPHIL COUNT INCREASED 1 0.0001
340 INITIAL INSOMNIA 1 0.0001
341 EAR DISCOMFORT 1 0.0001
342 INJECTION SITE WARMTH 2 0.0001
343 RHABDOMYOLYSIS 4 0.0001
344 PETECHIAE 1 0.0001
345 TRANSFUSION 1 0.0001
346 DYSPNOEA 54 0.0001
347 SCRATCH 1 0.0001
348 SUDDEN DEATH 1 0.0001
349 RENAL PAIN 1 0.0001
350 RETCHING 2 0.0001
351 LOSS OF CONSCIOUSNESS 12 0.0001
352 RASH PRURITIC 5 0.0001
353 SWELLING FACE 6 0.0001
354 CLOSTRIDIUM DIFFICILE INFECTION 2 0.0001
355 ASPIRATION 1 0.0001
356 RED BLOOD CELL SEDIMENTATION RATE INCREASED 1 0.0001
357 BLOOD PRESSURE DECREASED 6 0.0001
358 TRANSAMINASES INCREASED 2 0.0001
359 NERVE INJURY 1 0.0001
360 SEPSIS 10 0.0001
361 THROMBOCYTOPENIA 10 0.0001
362 NEPHROPATHY TOXIC 1 0.0001
363 FISTULA 1 0.0001
364 DERMATITIS CONTACT 1 0.0001
365 GASTRIC HAEMORRHAGE 1 0.0001
366 EYELID OEDEMA 1 0.0001
367 HYPOXIA 3 0.0001
368 PRODUCT PRESCRIBING ERROR 2 0.0001
369 MACULAR DEGENERATION 1 0.0001
370 RASH ERYTHEMATOUS 4 0.0001
371 SKIN EXFOLIATION 7 0.0001
372 SCHIZOPHRENIA 1 0.0001
373 PRESYNCOPE 2 0.0001
374 DISCOMFORT 5 0.0001
375 INTERCEPTED PRODUCT PREPARATION ERROR 1 0.0001
376 SPINAL OPERATION 1 0.0001
377 HYPERCALCAEMIA 1 0.0001
378 SECRETION DISCHARGE 1 0.0001
379 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 16 0.0001
380 TREMOR 13 0.0001
381 THERAPY CESSATION 4 0.0001
382 SEIZURE 9 0.0001
383 INFLAMMATION 4 0.0001
384 UNRESPONSIVE TO STIMULI 2 0.0001
385 SKIN ULCER 2 0.0001
386 RASH GENERALISED 2 0.0001
387 DEEP VEIN THROMBOSIS 5 0.0001
388 BLOOD CREATININE INCREASED 5 0.0001
389 ADVERSE REACTION 1 0.0001
390 EYE HAEMORRHAGE 1 0.0001
391 JOINT RANGE OF MOTION DECREASED 1 0.0001
392 QUALITY OF LIFE DECREASED 1 0.0001
393 GINGIVAL BLEEDING 1 0.0001
394 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 4 0.0001
395 RESPIRATORY DISTRESS 2 0.0001
396 NAUSEA 57 0.0001
397 HYPOMAGNESAEMIA 1 0.0001
398 HAEMOPTYSIS 2 0.0001
399 APHONIA 1 0.0001
400 MASS 1 0.0001
401 INCORRECT DRUG ADMINISTRATION DURATION 2 0.0001
402 PARAESTHESIA ORAL 1 0.0001
403 HYPOKINESIA 1 0.0001
404 COMPLICATION ASSOCIATED WITH DEVICE 1 0.0001
405 FLUID OVERLOAD 1 0.0001
406 DYSPHONIA 4 0.0001
407 BONE PAIN 4 0.0001
408 LABORATORY TEST ABNORMAL 2 0.0001
409 URINARY INCONTINENCE 2 0.0001
410 ADVERSE DRUG REACTION 6 0.0001
411 TOXIC EPIDERMAL NECROLYSIS 1 0.0001
412 INSURANCE ISSUE 1 0.0001
413 HIP ARTHROPLASTY 1 0.0001
414 SWELLING 6 0.0001
415 THERAPY PARTIAL RESPONDER 1 0.0001
416 PNEUMOTHORAX 1 0.0001
417 RESPIRATORY TRACT CONGESTION 1 0.0001
418 HALLUCINATION, AUDITORY 1 0.0001
419 PREMATURE DELIVERY 1 0.0001
420 THROMBOSIS 5 0.0001
421 VENTRICULAR TACHYCARDIA 1 0.0001
422 GENERALISED TONIC-CLONIC SEIZURE 1 0.0001
423 FUNGAL INFECTION 2 0.0001
424 SKIN DISORDER 2 0.0001
425 HYPOTENSION 12 0.0001
426 FACE OEDEMA 1 0.0001
427 CANDIDA INFECTION 1 0.0001
428 NEUTROPENIA 8 0.0001
429 ORTHOSTATIC HYPOTENSION 1 0.0001
430 AMENORRHOEA 1 0.0001
431 BLOOD TRIGLYCERIDES INCREASED 1 0.0001
432 HEAD DISCOMFORT 1 0.0001
433 INFECTION 8 0.0001
434 PELVIC PAIN 1 0.0001
435 PAIN IN EXTREMITY 16 0.0001
436 INJECTION SITE MASS 2 0.0001
437 AGRANULOCYTOSIS 1 0.0001
438 HEPATIC STEATOSIS 1 0.0001
439 NECK PAIN 3 0.0001
440 BACTERIAL INFECTION 1 0.0001
441 FOOT FRACTURE 1 0.0001
442 RENAL FAILURE 7 0.0001
443 PROTEINURIA 1 0.0001
444 MUSCULOSKELETAL DISORDER 1 0.0001
445 FEELING JITTERY 1 0.0001
446 CHOLESTASIS 1 0.0001
447 CONTUSION 5 0.0001
448 ATRIAL FIBRILLATION 5 0.0001
449 BLOOD PRESSURE SYSTOLIC INCREASED 1 0.0001
450 CHOKING 1 0.0001
451 PREGNANCY 1 0.0000
452 CYTOKINE RELEASE SYNDROME 1 0.0000
453 PRODUCT PHYSICAL ISSUE 1 0.0000
454 TREATMENT FAILURE 4 0.0000
455 HALLUCINATION, VISUAL 1 0.0000
456 DIARRHOEA 30 0.0000
457 HYPOACUSIS 2 0.0000
458 PRODUCT DISPENSING ERROR 1 0.0000
459 BLOOD PRESSURE INCREASED 7 0.0000
460 APPLICATION SITE PAIN 1 0.0000
461 GAMMA-GLUTAMYLTRANSFERASE INCREASED 1 0.0000
462 RASH PAPULAR 1 0.0000
463 PRODUCT USE IN UNAPPROVED INDICATION 11 0.0000
464 APPLICATION SITE PRURITUS 1 0.0000
465 DRUG INEFFECTIVE 58 0.0000
466 MUSCULAR WEAKNESS 5 0.0000
467 TINNITUS 2 0.0000
468 SHOCK 1 0.0000
469 ADVERSE EVENT 4 0.0000
470 UPPER RESPIRATORY TRACT INFECTION 2 0.0000
471 BURNING SENSATION 3 0.0000
472 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 3 0.0000
473 OEDEMA PERIPHERAL 5 0.0000
474 LIVER INJURY 1 0.0000
475 ENCEPHALOPATHY 1 0.0000
476 PNEUMONIA ASPIRATION 1 0.0000
477 SYNCOPE 4 0.0000
478 UNEVALUABLE EVENT 3 0.0000
479 GLYCOSYLATED HAEMOGLOBIN INCREASED 1 0.0000
480 INCORRECT DOSE ADMINISTERED 9 0.0000
481 DIPLOPIA 1 0.0000
482 DEAFNESS 1 0.0000
483 SEDATION 1 0.0000
484 MUSCULOSKELETAL PAIN 2 0.0000
485 APPLICATION SITE ERYTHEMA 1 0.0000
486 EAR INFECTION 1 0.0000
487 BLOOD BILIRUBIN INCREASED 1 0.0000
488 OEDEMA 2 0.0000
489 LIMB INJURY 1 0.0000
490 SKIN LESION 1 0.0000
491 MENTAL STATUS CHANGES 1 0.0000
492 PANCYTOPENIA 2 0.0000
493 WOUND 1 0.0000
494 ABDOMINAL DISCOMFORT 6 0.0000
495 RENAL IMPAIRMENT 3 0.0000
496 HYPONATRAEMIA 2 0.0000
497 PRODUCT DOSE OMISSION IN ERROR 1 0.0000
498 MULTIPLE ORGAN DYSFUNCTION SYNDROME 1 0.0000
499 FLATULENCE 2 0.0000
500 RED BLOOD CELL COUNT DECREASED 1 0.0000
501 HYPERSOMNIA 1 0.0000
502 DECREASED APPETITE 8 0.0000
503 LIVER FUNCTION TEST ABNORMAL 1 0.0000
504 NEEDLE ISSUE 1 0.0000
505 DYSSTASIA 1 0.0000
506 MALAISE 15 0.0000
507 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
508 DIZZINESS 17 0.0000
509 ABDOMINAL PAIN UPPER 7 0.0000
510 MATERNAL EXPOSURE DURING PREGNANCY 3 0.0000
511 HYPERTENSION 7 0.0000
512 INJECTION SITE RASH 1 0.0000
513 DRUG ADMINISTRATION ERROR 1 0.0000
514 HOSPITALISATION 5 0.0000
515 NERVOUS SYSTEM DISORDER 1 0.0000
516 DRUG-INDUCED LIVER INJURY 1 0.0000
517 PARAESTHESIA 5 0.0000
518 METABOLIC ACIDOSIS 1 0.0000
519 CHOLELITHIASIS 1 0.0000
520 IMPAIRED HEALING 1 0.0000
521 EXPIRED PRODUCT ADMINISTERED 1 0.0000
522 NEOPLASM MALIGNANT 2 0.0000
523 EYE PRURITUS 1 0.0000
524 TYPE 2 DIABETES MELLITUS 1 0.0000
525 PRODUCT QUALITY ISSUE 4 0.0000
526 MYALGIA 5 0.0000
527 FEELING ABNORMAL 7 0.0000
528 HAEMATURIA 1 0.0000
529 ILLNESS 3 0.0000
530 HAEMORRHAGE 3 0.0000
531 PLATELET COUNT DECREASED 3 0.0000
532 INCORRECT ROUTE OF DRUG ADMINISTRATION 1 0.0000
533 PAIN 17 0.0000
534 CRYING 1 0.0000
535 C-REACTIVE PROTEIN INCREASED 1 0.0000
536 PANIC ATTACK 1 0.0000
537 RESTLESSNESS 1 0.0000
538 EPISTAXIS 2 0.0000
539 HYPOAESTHESIA 4 0.0000
540 ASTHENIA 10 0.0000
541 HALLUCINATION 2 0.0000
542 COLITIS 1 0.0000
543 CONDITION AGGRAVATED 8 0.0000
544 DIABETES MELLITUS 2 0.0000
545 GAIT DISTURBANCE 5 0.0000
546 INJECTION SITE SWELLING 2 0.0000
547 INJECTION SITE PAIN 8 0.0000
548 DEPRESSED LEVEL OF CONSCIOUSNESS 1 0.0000
549 DISORIENTATION 1 0.0000
550 WEIGHT DECREASED 7 0.0000
551 DEVICE BREAKAGE 1 0.0000
552 CARDIAC ARREST 2 0.0000
553 INJECTION SITE ERYTHEMA 3 0.0000
554 POLLAKIURIA 1 0.0000
555 OSTEOARTHRITIS 1 0.0000
556 RECTAL HAEMORRHAGE 1 0.0000
557 MENTAL DISORDER 1 0.0000
558 PULMONARY OEDEMA 1 0.0000
559 THERAPEUTIC PRODUCT EFFECT DECREASED 1 0.0000
560 GASTROINTESTINAL DISORDER 2 0.0000
561 SUICIDAL IDEATION 2 0.0000
562 SKIN IRRITATION 1 0.0000
563 ARTHRALGIA 9 0.0000
564 RENAL DISORDER 1 0.0000
565 BLOOD GLUCOSE INCREASED 4 0.0000
566 DISEASE RECURRENCE 1 0.0000
567 MIGRAINE 2 0.0000
568 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1 0.0000
569 HEADACHE 13 0.0000
570 DRUG INTOLERANCE 2 0.0000
571 HYPOGLYCAEMIA 1 0.0000
572 ALOPECIA 4 0.0000
573 HEART RATE INCREASED 2 0.0000
574 AGGRESSION 1 0.0000
575 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1 0.0000
576 ABDOMINAL DISTENSION 2 0.0000
577 NERVOUSNESS 1 0.0000
578 SPEECH DISORDER 1 0.0000
579 ASPARTATE AMINOTRANSFERASE INCREASED 1 0.0000
580 EYE PAIN 1 0.0000
581 ANXIETY 5 0.0000
582 DEATH 15 0.0000
583 LETHARGY 1 0.0000
584 ABDOMINAL PAIN 4 0.0000
585 COVID-19 3 0.0000
586 SURGERY 1 0.0000
587 WHEEZING 1 0.0000
588 IRRITABILITY 1 0.0000
589 THERAPEUTIC RESPONSE DECREASED 1 0.0000
590 SUICIDE ATTEMPT 1 0.0000
591 STOMATITIS 1 0.0000
592 VERTIGO 1 0.0000
593 ALANINE AMINOTRANSFERASE INCREASED 1 0.0000
594 EXPOSURE DURING PREGNANCY 1 0.0000
595 PRODUCT USE ISSUE 3 0.0000
596 ANAEMIA 3 0.0000
597 PNEUMONIA 5 0.0000
598 PRODUCT DOSE OMISSION 1 0.0000
599 DEHYDRATION 2 0.0000
600 HEPATIC ENZYME INCREASED 1 0.0000
601 VISION BLURRED 2 0.0000
602 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1 0.0000
603 MOBILITY DECREASED 1 0.0000
604 UNDERDOSE 1 0.0000
605 PRODUCT DOSE OMISSION ISSUE 4 0.0000
606 HOT FLUSH 1 0.0000
607 DRUG INTERACTION 2 0.0000
608 INJECTION SITE HAEMORRHAGE 1 0.0000
609 CARDIAC FAILURE 1 0.0000
610 GASTROOESOPHAGEAL REFLUX DISEASE 1 0.0000
611 INFLUENZA LIKE ILLNESS 1 0.0000
612 CEREBROVASCULAR ACCIDENT 2 0.0000
613 URINARY TRACT INFECTION 2 0.0000
614 DEVICE ISSUE 1 0.0000
615 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 2 0.0000
616 OROPHARYNGEAL PAIN 1 0.0000
617 BREAST CANCER 1 0.0000
618 COUGH 3 0.0000
619 DYSPHAGIA 1 0.0000
620 HAEMOGLOBIN DECREASED 1 0.0000
621 ACCIDENTAL EXPOSURE TO PRODUCT 1 0.0000
622 CONSTIPATION 2 0.0000
623 FALL 3 0.0000
624 INFLUENZA 1 0.0000
625 ASTHMA 1 0.0000
626 PALPITATIONS 1 0.0000
627 JOINT SWELLING 1 0.0000
628 VISUAL IMPAIRMENT 1 0.0000
629 FATIGUE 6 0.0000
630 INSOMNIA 2 0.0000
631 MEMORY IMPAIRMENT 1 0.0000
632 DRUG DEPENDENCE 1 0.0000
633 CONFUSIONAL STATE 1 0.0000
634 DRUG DOSE OMISSION 1 0.0000
635 NO ADVERSE EVENT 1 0.0000
636 NASOPHARYNGITIS 1 0.0000
637 OVERDOSE 1 0.0000